Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma (Q33416533)
Jump to navigation
Jump to search
scientific article published on 9 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma |
scientific article published on 9 July 2014 |
Statements
1 reference
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma (English)
1 reference
Owen A O'Connor
1 reference
Michael Craig
1 reference
Wahid T Hanna
1 reference
Chien-Shing Chen
1 reference
Dixie-Lee Esseltine
1 reference
Rachel Neuwirth
1 reference
9 July 2014
1 reference
1 reference
166
1 reference
920-928
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference